Live Breaking News & Updates on Nick Abbott

Stay updated with breaking news from Nick abbott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ACM signs letter of intent for Facebook news deal


ACM signs letter of intent for Facebook news deal
May 4, 2021 11:28
Australian Community Media (ACM) is the latest publisher to enter into talks with Facebook which will see the latter pay for news published on its platform.
ACM announced it has signed a Letter Of Intent (LOI) for a multi-year agreement to provide news and information to millions of Australians through Facebook News, subject to both companies formally signing the deal.
Over 40 ACM regional, rural and suburban mastheads and publications will be covered by the agreement, including  Newcastle Herald, Canberra Times, Bendigo Advertiser, The Advocate, Katherine Times, Illawarra Mercury, and more. ....

New Zealand , Armstrong Creek , Australian Capital Territory , Andrew Hunter , Tony Kendall , Mark Casey , Warick Brown , Nick Abbott , News Corp , Country Press Australia , Times News Group , Australian Community Media , Letter Of Intent , Facebook News , Newcastle Herald , Canberra Times , Bendigo Advertiser , Katherine Times , Illawarra Mercury , Google News , News Group , Surf Coast Times , Bellarine Times , Armstrong Creek Times , Ballarat Times , Golden Plains Times ,

Jounce Therapeutics, Inc. (JNCE) Q1 2021 Earnings Call Transcript


Operator
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics First Quarter 2021 Earnings Conference Call. [Operator Instructions]. I will now turn the call over to your host, Malin Deon with Jounce Therapeutics. Please go ahead.
Malin Deon
Manager, Investor Relations & Corporate Communications
Thank you, operator. Good morning, and welcome to the Jounce Therapeutics first quarter conference call. This morning we issued a press release which outlines the topics that we plan to discuss today. The release is available in the Investors and Media section of our website at www.jouncetx.com.
Speaking on today s call will be our CEO and President, Dr. Rich Murray, who will review our pipeline progress, and key milestones, followed by our CSO, Dr. Dmitri Wiederschain, who will discuss our discovery efforts. Our CMO, Dr. Beth Trehu will then provide an update on our clinical activities, and lastly, our CFO, Kim Drapkin will review our first quar ....

Erich Murray , Raymond James , Edward Tenthoff Piper Sandler , Steve Seedhouse , Dmitri Wiederschain , Dmitri Wiederschainside , Swayam Ramakanth , Richard Murray , Nick Abbott , Beth Trehu , Kim Drapkin , Piper Sandler , Ryan Deschner , Zegbeh Jallah , Elizabeth Trehu , Malin Deon , Ted Tenthoff , Colleen Casey , Ryan Deschner Raymond James Financial Inc Analyst , Boris Peaker Cowen Co , Zegbeh Jallah Roth Capital Partners , Ramakanth Swayampakula Hc Wainwright Co , Investor Relations Corporate Communications , Jounce Therapeutics Inc , Jounce Therapeutics , Jounce Therapeutics First Quarter ,

Cellectis SA (CLLS) Q4 2020 Earnings Call Transcript


Cellectis SA (CLLS) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Cellectis SA (NASDAQ: CLLS)
Operator
Greetings. Welcome to the Cellectis Fourth Quarter and Full-Year 2020 Earnings Call. At this time, all participants are in a listen-only mode and a question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded.
At this time, I ll turn the conference over to Simon Harnest, Chief Investment Officer. Simon, you may begin.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to ....

France General , North Carolina , United States , Andre Choulika , Hartaj Singh , Jack Allen , Hartaj Singh Oppenheimer , Wangzhi Li , Gena Wang , Salveen Richter Goldman Sachs , Soumit Roy Jones , Soumit Roy , Ingrid Bensinger , Gena Wang Barclays , Salveen Richter , Yigal Nochomovitz , Ingrid Bensinger Kempen , Nick Abbott , Yigal Nochomovitz Citigroup , Simon Harnest , Wangzhi Li Ladenburg , Samantha Corwin William Blair , Carrie Brownstein , Michael Schmidt Guggenheim , Jean Pierre Garnier , Biren Amin ,

Precigen, Inc. (PGEN) Q4 2020 Earnings Call Transcript


Operator
Good day and welcome to Precigen Fourth Quarter and Year-End 2020 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] I would now like to turn the conference over to Steve Harasym. Please go ahead.
Steven Harasym
Head of Investor Relations
Thank you, operator and thank you all for joining us today. With me are Dr. Helen Sabzevari, President and CEO of Precigen and Tom Samuelson, Head of Financial Strategy. Helen will provide an update on our pipeline and technologies after which Tom will review our fourth quarter 2020 financial results. Following the prepared remarks, we will open the call to Q&A. ....

Ben Burnett Stifel , Jason Butler , Ben Burnett , Helen Sabzevari , Justin Walshb Riley , Steve Harasym , Chuck Whitesell , Justin Walsh , Deric Joseph , Tom Samuelson , Nick Abbott , Precigen Inc , Precigen Fourth Quarter , Results Conference , Chief Executive , Trans Ova Genetics , Precigen Exemplar , Okanagan Specialty Fruits , Wells Fargo , Fargo Securities , Trans Oval , Wells Fargo Securities , பென் பர்னெட் ஸ்டிபேல் , ஜேசன் பட்லர் , பென் பர்னெட் , சக் வைட்ஸெல் ,